These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37345043)

  • 1. The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies.
    Sarasin A
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
    Nikolaev S; Yurchenko AA; Sarasin A
    Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series.
    Yurchenko AA; Fresneau B; Borghese B; Rajabi F; Tata Z; Genestie C; Sarasin A; Nikolaev SI
    Commun Med (Lond); 2023 Aug; 3(1):109. PubMed ID: 37567969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
    Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
    J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
    Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
    Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
    Dupuy A; Sarasin A
    Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep intronic founder mutations identified in the
    Senju C; Nakazawa Y; Oso T; Shimada M; Kato K; Matsuse M; Tsujimoto M; Masaki T; Miyazaki Y; Fukushima S; Tateishi S; Utani A; Murota H; Tanaka K; Mitsutake N; Moriwaki S; Nishigori C; Ogi T
    Proc Natl Acad Sci U S A; 2023 Jul; 120(27):e2217423120. PubMed ID: 37364129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
    Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
    Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of repair proteins at unrepaired DNA damage distinguishes diseases with ERCC2 (XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophy.
    Boyle J; Ueda T; Oh KS; Imoto K; Tamura D; Jagdeo J; Khan SG; Nadem C; Digiovanna JJ; Kraemer KH
    Hum Mutat; 2008 Oct; 29(10):1194-208. PubMed ID: 18470933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
    Cleaver JE
    J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients.
    Yurchenko AA; Rajabi F; Braz-Petta T; Fassihi H; Lehmann A; Nishigori C; Wang J; Padioleau I; Gunbin K; Panunzi L; Morice-Picard F; Laplante P; Robert C; Kannouche PL; Menck CFM; Sarasin A; Nikolaev SI
    Nat Commun; 2023 May; 14(1):2561. PubMed ID: 37142601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shining a light on xeroderma pigmentosum.
    DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How history and geography may explain the distribution in the Comorian archipelago of a novel mutation in DNA repair-deficient xeroderma pigmentosum patients.
    Sarasin A; Munier P; Cartault F
    Genet Mol Biol; 2019; 43(1 suppl 1):e20190046. PubMed ID: 31930276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
    Daya-Grosjean L; Sarasin A
    Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients.
    Dumaz N; Drougard C; Sarasin A; Daya-Grosjean L
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10529-33. PubMed ID: 8248141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.